The future role of pharmacists and pharmacovigilance after the advent of the COVID-19 pandemic

La Gatta, A.; Ghidinelli, F.

doi:10.1016/j.vacune.2020.12.001

array:24 ["pii" => "S2445146021000261" "issn" => "24451460" "doi" => "10.1016/j.vacune.2020.12.001" "estado" => "S300" "fechaPublicacion" => "2021-05-01" "aid" => "177" "copyright" => "Elsevier España, S.L.U.. All rights reserved" "copyrightAnyo" => "2021" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Vacunas. 2021;22:127-8" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "Traduccion" => array:1 [ "en" => array:19 [ "pii" => "S1576988721000066" "issn" => "15769887" "doi" => "10.1016/j.vacun.2020.12.003" "estado" => "S300" "fechaPublicacion" => "2021-05-01" "aid" => "177" "copyright" => "Elsevier España, S.L.U." "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Vacunas. 2021;22:127-8" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "en" => array:10 [ "idiomaDefecto" => true "cabecera" => "Letter to the Editor" "titulo" => "The future role of pharmacists and pharmacovigilance after the advent of the COVID-19 pandemic" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "127" "paginaFinal" => "128" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Rol de farmacéuticos y farmacovigilancia tras la aparición de la pandemia de COVID-19" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "A. La Gatta, F. Ghidinelli" "autores" => array:2 [ 0 => array:2 [ "nombre" => "A." "apellidos" => "La Gatta" ] 1 => array:2 [ "nombre" => "F." "apellidos" => "Ghidinelli" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S2445146021000261" "doi" => "10.1016/j.vacune.2020.12.001" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2445146021000261?idApp=UINPBA00004N" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1576988721000066?idApp=UINPBA00004N" "url" => "/15769887/0000002200000002/v1_202106120702/S1576988721000066/v1_202106120702/en/main.assets" ] ] "itemSiguiente" => array:18 [ "pii" => "S2445146021000236" "issn" => "24451460" "doi" => "10.1016/j.vacune.2020.08.001" "estado" => "S300" "fechaPublicacion" => "2021-05-01" "aid" => "159" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Vacunas. 2021;22:129-30" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "en" => array:10 [ "idiomaDefecto" => true "cabecera" => "Letter to the Editor" "titulo" => "Simultaneous occurrence of seasonal influenza virus and SARS CoV-2 strains" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "129" "paginaFinal" => "130" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Circulación simultánea de virus de la gripe estacional y cepas SARS CoV-2" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "A. Talebi Bezmin Abadi, N. Petrosillo, A.R. Kavoor" "autores" => array:3 [ 0 => array:2 [ "nombre" => "A." "apellidos" => "Talebi Bezmin Abadi" ] 1 => array:2 [ "nombre" => "N." "apellidos" => "Petrosillo" ] 2 => array:2 [ "nombre" => "A.R." "apellidos" => "Kavoor" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S1576988720300406" "doi" => "10.1016/j.vacun.2020.08.001" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1576988720300406?idApp=UINPBA00004N" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2445146021000236?idApp=UINPBA00004N" "url" => "/24451460/0000002200000002/v1_202106241110/S2445146021000236/v1_202106241110/en/main.assets" ] "itemAnterior" => array:18 [ "pii" => "S2445146021000194" "issn" => "24451460" "doi" => "10.1016/j.vacune.2021.05.005" "estado" => "S300" "fechaPublicacion" => "2021-05-01" "aid" => "184" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Vacunas. 2021;22:125-6" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "en" => array:10 [ "idiomaDefecto" => true "cabecera" => "Letter to the editor" "titulo" => "Governments and vaccination against COVID-19" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "125" "paginaFinal" => "126" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Los gobiernos y la vacunación contra la COVID-19" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "L.A. Javier Silva, E.A. Rosario Pacahuala" "autores" => array:2 [ 0 => array:2 [ "nombre" => "L.A." "apellidos" => "Javier Silva" ] 1 => array:2 [ "nombre" => "E.A." "apellidos" => "Rosario Pacahuala" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S1576988721000133" "doi" => "10.1016/j.vacun.2021.03.001" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1576988721000133?idApp=UINPBA00004N" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2445146021000194?idApp=UINPBA00004N" "url" => "/24451460/0000002200000002/v1_202106241110/S2445146021000194/v1_202106241110/en/main.assets" ] "en" => array:11 [ "idiomaDefecto" => true "cabecera" => "Letter to the Editor" "titulo" => "The future role of pharmacists and pharmacovigilance after the advent of the COVID-19 pandemic" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "127" "paginaFinal" => "128" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "A. La Gatta, F. Ghidinelli" "autores" => array:2 [ 0 => array:4 [ "nombre" => "A." "apellidos" => "La Gatta" "email" => array:1 [ 0 => "alessandra.lagatta03@gmail.com" ] "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "*" "identificador" => "cor0005" ] ] ] 1 => array:3 [ "nombre" => "F." "apellidos" => "Ghidinelli" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "b" "identificador" => "aff0010" ] ] ] ] "afiliaciones" => array:2 [ 0 => array:3 [ "entidad" => "Recordati S.p.A., Milan, Italy" "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:3 [ "entidad" => "Spedali Civili di Brescia, Brescia, Italy" "etiqueta" => "b" "identificador" => "aff0010" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Rol de farmacéuticos y farmacovigilancia tras la aparición de la pandemia de COVID-19" ] ] "textoCompleto" => "The unforeseen arrival of the coronavirus disease 2019 (COVID-19) has completely subverted our daily life.Pharmacists have been representing a crucial role in the fight against SARS-CoV2 virus.The importance of these figures has been extensively confirmed during this pandemic.<a class="elsevierStyleCrossRef" href="#bib0030">1</a>This health crisis has created pandemic-related challenges and it has laid the foundations for a future massive change in this world.First, when the vaccine against COVID-19 is released, pharmacists will be assigned the role of primary frontline health workers in order to provide immunization to people, as demonstrated by community pharmacists who have been well-placed to provide accessible coverage in the past.<a class="elsevierStyleCrossRef" href="#bib0035">2</a>Second, as reported by John C. Hayden et al., social distancing has obliged pharmacists to reinvent the way by which they dispense advice and medications.<a class="elsevierStyleCrossRef" href="#bib0040">3</a>For example, virtual consultations have become common, especially among fragile people. In addition, the implementation of systems to provide drugs to patients was necessary to reduce non-essential medical and pharmaceutical visits and to maintain a good quality of service.Third, some innovations have been introduced in many countries and they may be preserved in the future, including the electronic prescriptions with primary care eliminating the legislative requirement for paper scripts.Thus, pharmacists can provide a decisive help to health care system in this pandemic.Not only has this pandemic conferred new opportunities among pharmacies and patients, but also it has opened new scenarios in the field of pharmacovigilance.Monitoring the efficacy and safety profiles of medications constitutes a priority for healthcare professionals and patients, especially during the COVID-19 period for drugs administered to treat this infection in ‘off-label use’.Unfortunately, there is not currently enough data to create worldwide guidelines for a controlled and safe use of all medications administrated for the treatment of COVID-19 infection, outlining the increasing need to promote scientific research.It should be useful to control patient safety by rapid reporting of adverse drug reactions (ADRs).This aspect, for example, may be achieved by drug information services that provide 24-h professional advice to patients and healthcare workers after being exposed to medications, as reported by Tuccori et al.<a class="elsevierStyleCrossRef" href="#bib0045">4</a>Some hospitals have already commenced to evaluate the incidence, type and risk factors associate with ADRs among patients with COVID-19.A retrospective study with two hundred seventeen patients with COVID-19 was conducted by the First Hospital of Changsha in China.<a class="elsevierStyleCrossRef" href="#bib0050">5</a>It was demonstrated that the prevalence of ADRs was approximately 37% in patients treated with lopinavir, umifenovir and chloroquine, emphasizing the need of active monitoring of adverse reactions that can occur to patients with COVID-19.Another increasing point of interest in pharmacovigilance concerning the ADRs is represented by the poor adherence of patients to anti-COVID-19 medications.The correct identification of risk factors for the onset of adverse reactions is basically vital to choose the most appropriate antiretroviral regimen for the treatment of patients.A rapid signaling of all ADRs related to anti-COVID-19 medications can facilitate the role of health care workers in the COVID-19 era and, thus, increase the level of patients’ adherence." "pdfFichero" => "main.pdf" "tienePdf" => true "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0015" "bibliografiaReferencia" => array:5 [ 0 => array:3 [ "identificador" => "bib0030" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Pharmacists and COVID-19" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "A. Elbeddini" 1 => "T. Prabaharan" 2 => "S. Almasalkhi" 3 => "C. Tran" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "J Pharm Policy Pract" "fecha" => "2020" "volumen" => "3" "paginaInicial" => "1" "paginaFinal" => "4" ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0035" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Integrating pharmacies into public health program planning for pandemic influenza vaccine response" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "T.J. Fitzgerald" 1 => "Y. Kang" 2 => "C.B. Bridges" 3 => "T. Talbert" 4 => "S.J. Vagi" 5 => "B. Lamont" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.vaccine.2016.09.020" "Revista" => array:6 [ "tituloSerie" => "Vaccine" "fecha" => "2016" "volumen" => "34" "paginaInicial" => "5643" "paginaFinal" => "5648" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/27686834" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0040" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The challenges of COVID-19 for community pharmacists and opportunities for the future" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "J.C. Hayden" 1 => "R. Parkin" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1017/ipm.2020.52" "Revista" => array:2 [ "tituloSerie" => "Ir J Psychol Med" "fecha" => "2020" ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0045" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The impact of the COVID-19 “infodemic” on drug-utilization behaviors: implications for pharmacovigilance" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "M. Tuccori" 1 => "I. Convertino" 2 => "S. Ferraro" 3 => "E. Cappello" 4 => "G. Valdiserra" 5 => "D. Focosi" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s40264-020-00965-w" "Revista" => array:2 [ "tituloSerie" => "Drug Saf" "fecha" => "2020" ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0050" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Incidence of adverse drug reactions in COVID-19 patients in China: an active monitoring study by Hospital Pharmacovigilance System" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "J. Sun" 1 => "X. Deng" 2 => "X. Chen" 3 => "J. Huang" 4 => "S. Huang" 5 => "Y. Li" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/S0009-9236(99)70116-5" "Revista" => array:5 [ "tituloSerie" => "Clin Pharmacol Ther" "fecha" => "2020" "paginaInicial" => "1" "paginaFinal" => "7" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/9951425" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/24451460/0000002200000002/v1_202106241110/S2445146021000261/v1_202106241110/en/main.assets" "Apartado" => array:4 [ "identificador" => "91117" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Letters to the editor" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/24451460/0000002200000002/v1_202106241110/S2445146021000261/v1_202106241110/en/main.pdf?idApp=UINPBA00004N&text.app=https://www.elsevier.es/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2445146021000261?idApp=UINPBA00004N"]

ISSN: 2445-1460

Official journal of the Asociación Española de Vacunología (AEV) Vacunas is a peer-reviewed journal supported by an advisory board of experts in the field of vaccinology. The aim of the journal is to contribute to the dissemination of the scientific advances made in the area of basic and applied research in the field of vaccine-preventable diseases in humans. It places special emphasis on aspects associated with planning and evaluation (epidemiology of vaccine-preventable diseases, development of vaccination programs, evaluation of the efficacy, effectiveness and efficiency of vaccinations). Vacunas publishes, in Spanish and in English, Editorials, Original Articles, Special Articles, Reviews, Strategies and Vaccination Programs. There are also sections on Literature Reviews, News and on Congresses associated with vaccinations. The peer review process is done anonymously by reviewers with expertise in the area of knowledge of each manuscript as well as experts in methodology or statistics, as determined by the Editorial board, which works towards maintaining an efficient editorial process in order for the manuscripts to be published as soon as possible.

See more Open Access Option

Indexed in:

Scopus, EMBASE/Excerpta Médica e IBECS

Subscribe:

Citescore

CiteScore measures average citations received per document published.

Citescore 2023

3.9

SJR

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

SJR 2023

0.423

SNIP

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

SNIP 2023

0.421

View more metrics

Journal Information

Previous article | Next article

Vol. 22. Issue 2.

Pages 127-128 (May - August 2021)

Export reference

Download PDF

Article

These are the options to access the full texts of the publication Vacunas (English Edition)

Subscriber

If you already have your login data, please click here .

If you have forgotten your password you can you can recover it by clicking here and selecting the option “I have forgotten my password”

Subscribe to

Vacunas (English Edition)

More information

Purchase

Purchase article

Purchasing article the PDF version will be downloaded

Price 19.34 €

Purchase now

Contact

Phone for subscriptions and reporting of errors

From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.

Calls from Spain

932 415 960

Calls from outside Spain

+34 932 415 960

E-mail

atencionalcliente@elsevier.com

Indexed in:

Follow us:

Subscribe:

Article

Subscribe to our newsletter